(Q32154892)

6 July 2017

1 reference

title

Use of ristocetin cofactor activity in the management of von Willebrand disease (English)

1 reference

6 July 2017

1

Ewenstein BM

1 reference

6 July 2017

1 January 2001

1 reference

6 July 2017

1 reference

6 July 2017

7 Suppl 1

1 reference

6 July 2017

10-15

1 reference

Von Willebrand's disease.

6 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Wingless armadillos and their clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Biochemistry and genetics of von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Platelet von Willebrand factor in inherited and acquired bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Clinical management of patients with von Willebrand's disease with a VHP vWF concentrate: the French experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP--a survey of European physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

Summary of a workshop on potency and dosage of von Willebrand factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00096.X

10.1046/J.1365-2516.2001.00096.X

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference

PubMed ID

11240613